Advertisement

Meyka AI - Contribute to AI-powered stock and crypto research platform
Meyka Stock Market API - Real-time financial data and AI insights for developers
Advertise on Meyka - Reach investors and traders across 10 global markets
Loading...

Genus plc

GENSFPNK
Healthcare
Biotechnology
$35.97
$0.005(0.01%)
U.S. Market opens in NaNh NaNm

Genus plc (GENSF) Stock Overview

Explore Genus plc’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap2.4B
P/E Ratio37.53
EPS (TTM)$0.95
ROE0.10%
Fundamental Analysis

AI Price Forecasts

1 Month$40.85
3 Months$42.21
1 Year Target$36.58

GENSF Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Genus plc (GENSF) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 45.43, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $36.58.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 37.53 and a market capitalization of 2.4B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
N/A
5-Day Change
-0.01%
1-Month Change
-3.45%
3-Month Change
2.32%
6-Month Change
2.32%
Year-to-Date (YTD) Change
2.76%
1-Year Change
43.29%
3-Year Change
2.38%
5-Year Change
-48.18%
All-Time (Max) Change
1698.25%

Contact Information

44 1256 347 100
Matrix House, Basingstoke, NaN, RG21 4DZ

Company Facts

35,000 Employees
IPO DateSep 11, 2009
CountryGB
Actively Trading

Frequently Asked Questions